Professional Background:

Sam Graf is Head of Innovation and Partnerships at Cyclotek. Following the completion of his Master of Science at the University of Melbourne, Sam worked at the Peter MacCallum Cancer Centre as a Clinical Trial Coordinator. In 2022, Sam joined the team at Cyclotek to manage Cyclotek’s R&D projects and industry-academia collaborations.

Research Interests:

Sam completed his Master of Science under Professor Paul Donnelly at the University of Melbourne. There, his research focused on the synthesis and characterisation of novel Rhenium based theranostics for the diagnosis and treatment of prostate cancer. At Cyclotek, Sam has been involved in various research projects involving the translation of novel small molecules and antibody fragments for the diagnosis and treatment of multiple diseases.